Vivanza Biosciences Share Price
Small Cap | Pharmaceuticals and health care | BSE: 530057
₹2.62 
-0.05 (-1.87 %)
Last Updated: 25 Feb 2025 12:00 AM
BEARISH
Overview
Open (₹) 2.62
High (₹) 2.62
Low (₹) 2.62
Prev. Close (₹) 2.67
Volume 23,489
VWAP (₹) 2.62
ROCE (%) 15.13
Industry P/E 43.77
TTM P/E -131.00
P/B Ratio 2.26
Market Cap (₹) Cr.10.48
Dividend Yield (%)--
EPS (₹) 0.14
ROE12.07%
Sales Growth (%) 56.32
Profit Growth (%)-8.52
Day Range
2.622.62
52 Week Range
2.009.54
Historical Returns
Returns (6M)
-35.63 %
Returns (1Y)
-67.77 %
Returns (3Y)
-83.62 %
Returns (5Y)
109.6 %
Returns (6M)
-35.63 %
Returns (1Y)
-67.77 %
Returns (3Y)
-83.62 %
Returns (5Y)
109.6 %
SWOT Analysis
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
Technicals
Technical Rating
BEARISHRSI 58.28
MFI 28.27
ATR 0.17
Commodity Channel Index 8.25
ROC125 -40.32
ROC21 -12.67
Williams %R -34.04
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 | 2.62 |
| Week Ago | 2.67 | 2.67 | 2.67 | 2.67 | 2.67 | 2.67 | 2.67 |
| Month Ago | 3.11 | 3.15 | 3.20 | 3.06 | 3.02 | 2.97 | 2.93 |
EMA & SMA
2.62
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
11
5 Day 2.75
9 Day 2.56
10 Day 2.51
12 Day 2.46
14 Day 2.47
20 Day 2.64
26 Day 2.74
50 Day 3.09
100 Day 3.47
200 Day 4.29
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| RAJ KUMAR BAID | bulk | Sell | 06 Feb, 2025 | ₹2.39 | 2,22,222 | BSE |
| VISHAL CHINUBHAI SUTHAR HUF | bulk | Sell | 08 Jan, 2025 | ₹3.67 | 10,40,315 | BSE |
| SWATI VISHAL SUTHAR | bulk | Sell | 08 Jan, 2025 | ₹3.68 | 2,43,859 | BSE |
| BIBHAS BHAGWANDAS ASAR | bulk | Sell | 08 Jan, 2025 | ₹3.61 | 3,00,000 | BSE |
| VISHAL CHINUBHAI SUTHAR HUF | bulk | Buy | 08 Jan, 2025 | ₹3.60 | 3,000 | BSE |
| JITEN KUMAR BISWAS | bulk | Buy | 01 Jan, 2025 | ₹3.69 | 2,18,000 | BSE |
| SWATI VISHAL SUTHAR | bulk | Sell | 27 Dec, 2024 | ₹3.49 | 2,64,209 | BSE |
| KALPESH VITHALDAS RAMI | bulk | Sell | 27 Dec, 2024 | ₹3.48 | 3,29,783 | BSE |
| KALPESH VITHALDAS RAMI | bulk | Sell | 26 Dec, 2024 | ₹3.29 | 25,100 | BSE |
| ANANT WEALTH CONSULTANTS PRIVATE LIMITED | bulk | Sell | 26 Dec, 2024 | ₹3.16 | 4,06,881 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 19 Dec, 2024 | Parth Hemant Parikh | Disposal | ₹3.60 | 4,12,204 | BSE |
| 11 Dec, 2024 | Parth Hemant Parikh | Disposal | ₹3.47 | 10,00,000 | BSE |
| 11 Dec, 2024 | Parth Hemant Parikh | Disposal | ₹3.30 | 4,38,796 | BSE |
| 06 Dec, 2024 | Parth Hemant Parikh | Disposal | ₹3.54 | 1,85,154 | BSE |
| 05 Dec, 2024 | Parth Hemant Parikh | Disposal | ₹3.62 | 78,176 | BSE |
| 04 Dec, 2024 | Parth Hemant Parikh | Disposal | ₹3.72 | 1,65,137 | BSE |
| 30 Nov, 2024 | Parth Hemant Parikh | Disposal | ₹3.72 | 2,33,101 | BSE |
| 30 Nov, 2024 | Parth Hemant Parikh | Disposal | ₹3.86 | 2,33,101 | BSE |
| 28 Nov, 2024 | Parth Hemant Parikh | Disposal | ₹3.95 | 2,33,101 | BSE |
| 28 Nov, 2024 | Parth Hemant Parikh | Disposal | ₹4.06 | 2,33,101 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 24 Jan, 2023 | Stock split from Rs. 10/- to Re. 1/-. | 24 Mar, 2023 | 24 Mar, 2023 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 12 Feb, 2025 | BSE India | INTEGRATED FILING- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2024. |
| 31 Jan, 2025 | BSE India | Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. to consider and approve the Un-audited Financial Results for the Quarter and Nine months ended 31st December, 2024. |
| 31 Jan, 2025 | BSE India | Outcome of the Board Meeting held on 31st January, 2025 at 04:00 P.M. inter alia considered and approved Un-audited Financial Results for the Quarter and Nine Months Ended 31st December, 2024. |
| 30 Jan, 2025 | BSE India | Intimation regarding Resignation of Company Secretary & Compliance Officer pursuant to Regulation 30 of SEBI(LODR) Regulations, 2015. |
| 24 Jan, 2025 | BSE India | Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve 1. Unaudited Standalone and Consolidated Results along with Limited Review Report for the Quarter and Nine Months ended 31st December, 2024;\r\n\r\n2. Any other business with the permission of Chairman. |
| 15 Jan, 2025 | BSE India | Non-Applicability of Statement of Deviation or variation under Regulation 32 of SEBI (LODR) Regulations, 2015. |
| 18 Oct, 2024 | BSE India | We hereby submit the Disclosure of Non-applicability of Regulation 23(9) of SEBI(LODR) Regulations, 2015 for the Quarter and Half Year ended on 30th September, 2024. |
| 17 Oct, 2024 | BSE India | Pursuant to provisions of Regulation 33 of SEBI(LODR) Regulations, 2015, the Board of Directors at its meeting held on 17th October, 2024 at 5:00 PM has approved Unaudited Quarterly and Half Yearly Financial Results for the period ended 30th September, 2024. |
| 17 Oct, 2024 | BSE India | Pursuant to provisions of Regulation 33 of SEBI (LODR) Regulations, 2015, Board of DIrectors has approved Unaudited Financial Results for the Quarter and Half Year Ended 30th September, 2024. |
| 10 Oct, 2024 | BSE India | Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2024 ,inter alia, to consider and approve Notice is hereby given that meeting of Board of Directors scheduled to be held on Thursday, 17th October, 2024 at 5:00 PM at Registered Office of the Company. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 20 Feb, 2025 | 31 Jan, 2025 |
| Quarterly Results | -- | 11 Oct, 2024 | 17 Oct, 2024 |
| Quarterly Results | -- | 05 Aug, 2024 | 08 Aug, 2024 |
| Others | Inter alia, 1) To consider and approve the Director's Report and Secretarial Audit Report along with annexure for the F.Y. 2023-24; | 17 Jul, 2024 | 05 Jul, 2024 |
| Audited Results | -- | 22 Apr, 2024 | 30 Apr, 2024 |
| Quarterly Results | -- | 31 Jan, 2024 | 06 Feb, 2024 |
| Quarterly Results | -- | 12 Oct, 2023 | 26 Oct, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 10 Aug, 2023 |
| A.G.M. | Inter alia, to consider and approve the Directors Report and Secretarial Audit Report along with annexure for the Financial Year 2022-23. | 28 Jun, 2023 | 30 Jun, 2023 |
| Audited Results | -- | 29 Mar, 2023 | 25 Apr, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Vivanza Biosciences
Vivanza Biosciences is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 14.41 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1982
Managing Director
Mr. J A Mehta
NSE Symbol
--
Vivanza Biosciences Management
| Name | Designation |
|---|---|
| Mr. J A Mehta | Managing Director |
| Mr. H A Parikh | Director |
| Ms. Rina Kumari | Director |
| Mr. A P Shah | Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,613.60  ₹1,639.50(-1.58%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,726.40  ₹5,702.55(0.42%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,463.35 ₹1,476.75(-0.91%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,342.10 ₹2,298.80(1.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,128.15 ₹1,164.55(-3.13%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Vivanza Biosciences
What is the share price of Vivanza Biosciences?
The share price of Vivanza Biosciences on 25 Feb, 2025 is ₹ 2.62.
What is 52W high and 52W low share price of Vivanza Biosciences?
The highest and lowest 52W share prices of Vivanza Biosciences are ₹ 11.720 and ₹ 3.000
What is the market cap of Vivanza Biosciences?
The market capitalization of Vivanza Biosciences as of 25 Feb, 2025 is ₹ 10.48 Crores
What is the P/E ratio of Vivanza Biosciences?
The current P/E ratio of Vivanza Biosciences as of 25 Feb, 2025 is 43.77
What is the PB ratio of Vivanza Biosciences?
The PB ratio of Vivanza Biosciences as of 25 Feb, 2025 is 2.26
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)